Prognosis and epidemiology of amyotrophic lateral sclerosis: Analysis of a clinic population, 1997–2011

Summary Amyotrophic lateral sclerosis is a disease with highly variable clinical features and prognosis. We analyzed the prognostic indicators of age, sex, bulbar or spinal onset, body mass index (BMI), and forced vital capacity (FVC) for 728 deceased patients from the Emory ALS Clinic. The median overall survival was 29.8 months from symptom onset, 15.8 months from diagnosis, and 14.3 months from the initial clinic visit. While univariate analyses revealed that each of the identified clinical features was strongly associated with patient survival, in multivariable analyses only age, BMI, and FVC measured at the first clinic visit were independent prognostic indicators; bulbar onset and sex were not significantly associated with survival prognosis after adjustment for the other clinical features.

[1]  A. Chiò,et al.  Phenotypic heterogeneity of amyotrophic lateral sclerosis: a population based study , 2011, Journal of Neurology, Neurosurgery & Psychiatry.

[2]  E. Beghi,et al.  Prognostic factors in ALS: A critical review , 2009, Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases.

[3]  E. Beghi,et al.  Predictors of long survival in amyotrophic lateral sclerosis: A population-based study , 2008, Journal of the Neurological Sciences.

[4]  E. Beghi,et al.  Descriptive epidemiology of amyotrophic lateral sclerosis: new evidence and unsolved issues , 2007, Journal of Neurology, Neurosurgery, and Psychiatry.

[5]  S. Appel,et al.  Predictability of disease progression in amyotrophic lateral sclerosis , 2006, Muscle & nerve.

[6]  C. Tanner,et al.  Effect of Reproductive Factors and Postmenopausal Hormone Use on the Risk of Amyotrophic Lateral Sclerosis , 2006, Neuroepidemiology.

[7]  S. Appel,et al.  Amyotrophic lateral sclerosis: early predictors of prolonged survival , 2006, Journal of Neurology.

[8]  S. Sasaki,et al.  Descriptive Epidemiology of Amyotrophic Lateral Sclerosis in Japan, 1995-2001 , 2005, Journal of epidemiology.

[9]  Adriano Chiò,et al.  Acute migraine treatment with droperidol , 2003, Neurology.

[10]  S. Rudnicki Estrogen replacement therapy in women with amyotrophic lateral sclerosis , 1999, Journal of the Neurological Sciences.

[11]  J. Annegers,et al.  Prognosis of amyotrophic lateral sclerosis and the effect of referral selection , 1995, Journal of the Neurological Sciences.

[12]  J. Slattery,et al.  The prognosis of adult-onset motor neuron disease: a prospective study based on the Scottish Motor Neuron Disease Register , 1993, Journal of Neurology.

[13]  E. Mukai,et al.  [The natural history of ALS in a specified population, with comments on risk factors, prognosis and symptomatic treatments]. , 1989, Rinsho shinkeigaku = Clinical neurology.

[14]  J. Leach,et al.  Survival prediction in amyotrophic lateral sclerosis , 1989, Muscle & nerve.

[15]  L. Forsgren,et al.  Epidemiology of motor neuron disease in northern Sweden , 1983, Acta neurologica Scandinavica.

[16]  R. Fogelholm,et al.  Amyotrophic lateral sclerosis in Middle‐Finland: an epidemiological study , 1983, Acta neurologica Scandinavica.

[17]  M. de Carvalho Natural history of young-adult amyotrophic lateral sclerosis. , 2009, Neurology.

[18]  S. Vollset,et al.  Prognostic factors and survival in amyotrophic lateral sclerosis. , 1994, Neuroepidemiology.